-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, E/024n2yNlZ2IIbcpziPYD4Qa21ooD7lXW1wvKF30VxJ8RqZTvEur+gR3ALMa96o jKHUMn7i8k70QloJXBsnMA== 0001079974-02-000495.txt : 20021009 0001079974-02-000495.hdr.sgml : 20021009 20021009162039 ACCESSION NUMBER: 0001079974-02-000495 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20021009 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: VITRO DIAGNOSTICS INC CENTRAL INDEX KEY: 0000793171 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 841012042 STATE OF INCORPORATION: NV FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-41585 FILM NUMBER: 02785229 BUSINESS ADDRESS: STREET 1: 12635 E. MONTVIEW BLVD. STREET 2: SUITE 218 CITY: AURORA STATE: CO ZIP: 80010 BUSINESS PHONE: (720) 859-4120 MAIL ADDRESS: STREET 1: 12635 E. MONTVIEW BLVD. STREET 2: SUITE 218 CITY: AURORA STATE: C0 ZIP: 80010 FORMER COMPANY: FORMER CONFORMED NAME: IMPERIAL MANAGEMENT INC DATE OF NAME CHANGE: 19870201 FORMER COMPANY: FORMER CONFORMED NAME: LABTEK INC DATE OF NAME CHANGE: 19870217 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: HANSEN LLOYD G CENTRAL INDEX KEY: 0001196860 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 2646 SW MAPP RD CITY: PLAM CITY STATE: FL ZIP: 34990 BUSINESS PHONE: 5612813233 MAIL ADDRESS: STREET 1: 2646 SW MAPP RD CITY: PALM CITY STATE: FL ZIP: 34990 SC 13D/A 1 vitro13dahansen_10032002.txt SCHEDULE 13D AMENDMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 1) * Vitro Diagnostics, Inc. ("VODG") -------------------------------- (Name of Issuer) Common Stock, $.001 par value per share --------------------------------------- (Title of Class of Securities) 928501303 -------------- (CUSIP Number) David J. Babiarz, Esq., Overton, Babiarz & Associates, P.C., 7720 E. Belleview Avenue, Suite 200, Greenwood Village, Colorado 80111, (303) 779-5900 ------------------------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) October 07, 2002 ----------------------------------------------------- (Date of Event Which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D/A, and is filing this schedule because of ss.ss. 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box _____. Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See ss. 240.13d-7(b) for other parties to whom copies are to be sent. *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 928501303 --------- 1 Name of Reporting Person Lloyd G. Hansen 2 Check the Appropriate Box if a Member of a Group a [ ] b [ ] 3 SEC USE ONLY 4 Source of Funds N/A 5 Check Box if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e) [ ] 6 Citizenship or Place of Organization United States of America NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7 Sole Voting Power: 1,040,000 8 Shared Voting Power: --00-- 9 Sole Dispositive Power: 1,040,000 10 Shared Dispositive Power: --00-- 11 Aggregate Amount Beneficially Owned by Each Reporting Person: 1,040,000 12 Check Box if the Aggregate Amount in Row (11) Excludes Certain Shares [ ] 13 Percent of Class Represented by Amount in Row (11): 11.28% 14 Type of Reporting Person IN 2 Item 1: SECURITY AND ISSUER This Schedule relates to the disposition of beneficial ownership of Common Stock, $.001 par value per share, of Vitro Diagnostics, Inc. (hereinafter the "Company"), whose principal place of business is located at 12635 E. Montview Blvd., Aurora, Colorado 80010. Item 2: IDENTITY AND BACKGROUND a. This Amendment to Schedule 13D is being filed by Lloyd G. Hansen, who is sometimes referred to in this Amendment as the Reporting Person. b. Address: 2646 SW Mapp Road, Suite 304, Palm City, Florida 34990 c. Occupation: Mr. Hansen is a private investor. d. During the past five years, the Reporting Person has not been convicted in any criminal proceeding. e. During the past five years, the Reporting Person has not been a party to a civil proceeding before a judicial or administrative body of competent jurisdiction resulting in a judgment, decree or final order enjoining future violation of, prohibiting or mandating activities subject to, Federal or state securities laws. f. Citizenship: United States of America Item 3: SOURCE OF FUNDS OR OTHER CONSIDERATION N/A Item 4: PURPOSE OF TRANSACTION The transaction which is the subject of this Amendment was an exchange of common stock of the Company for stock of a privately held entity. The transaction was designed to diversify the investment portfolio of The Barnabas Trust, of which Mr. Hansen is a trustee. a. Mr. Hansen will continuously evaluate his holdings in the Company and make additional acquisitions or dispositions, in his discretion. Other than that, the Reporting Person has no plans for the acquisition or disposition by any person of additional securities of the Company. b-j. The Reporting Person has no plans of the type described in these sections of Item 4 of the Schedule. 3 Item 5: INTEREST IN SECURITIES OF THE ISSUER a. As of the date of the filing of this Amendment No. 1, the Reporting Person is deemed to beneficially own 1,040,000 shares of common stock of the Company, or 11.28% of the common stock outstanding as of the date of this Amendment. b. Mr. Hansen has the sole power to vote and dispose of the common stock owned by him. c. Effective October 7, 2002, the Reporting Person indirectly disposed of 200,000 shares of the Company. These shares were formally owned by the Barnabas Trust, of which the Reporting Person is a trustee. The shares of the Company were exchanged by the Trust in a private transaction for 2,400 shares of a private company called Sound Technologies, Inc. The shares of the private company have no ascertainable value at this time. d. Not applicable. e. Not applicable. Item 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER None. Item 7: MATERIAL TO BE FILED AS EXHIBITS There is no material required to be filed as exhibits to this Schedule. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in the Statement to Schedule 13D/A is true, correct and complete. /s/ Lloyd G. Hansen Date: October 7, 2002 - ---------------------- --------------- Lloyd G. Hansen 4 -----END PRIVACY-ENHANCED MESSAGE-----